Eric G Carter insider trades

Open-market stock purchases and sales by Eric G Carter, Director at AEON Biopharma, Inc, from SEC Form 4 filings since Dec 31, 2009.

Recent trades

DateStockTradeValue
Jun 17, 2026AEON AEON Biopharma, IncBought (not open market)—

Companies traded

  • AEON AEON Biopharma, Inc: other filings, last Jun 17, 2026
  • ADVM Adverum Biotechnologies, Inc: other filings, last Jun 23, 2020
  • ALDR Alder Biopharmaceuticals Inc: other filings, last Apr 23, 2018
  • KG King Pharmaceuticals Inc: other filings, last Jan 31, 2011

Get free alerts when Eric G Carter files a new trade →